← Open Payments lookup

DAVID SEPULVEDA: Open Payments

NPI 1316100381 · GONZALES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,197 in 73 payments from 22 companies in 2025. Trend: 2023 $1,166 · 2024 $1,264 · 2025 $1,197

Food & beverage: $1,197
CompanyPaymentsAmount
ABBVIE INC.28$292
GlaxoSmithKline, LLC.9$164
Lilly USA, LLC5$85
Bayer Healthcare Pharmaceuticals Inc.4$79
Novo Nordisk Inc4$65
Antares Pharma, Inc.1$64
Takeda Pharmaceuticals U.S.A., Inc.2$56
Abbott Laboratories2$50
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$44
Exact Sciences Corporation2$41

Products named: UBRELVY, TRELEGY ELLIPTA, VRAYLAR, QULIPTA, Kerendia, JARDIANCE, XYOSTED, TRINTELLIX.

Industry payments across LA — which companies pay providers there.